Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Biocon Ltd.
NSE: BIOCON
|
BSE: 532523
|
ISIN: INE376G01013
|
Industry: Biotechnology
US FDA Approval
|
Mid-range Performer
377.0500
-6.50
(
-1.69
%)
NSE
Mar 16, 2026
15:59 PM
26.10% Gain from 52W Low
Volume:
2.7M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Biocon Ltd.
13 Nov 2025
US FDA Approval
377.05
-1.69%
Result Update:Biocon
Buy:
Biocon Ltd.
by
Axis Direct
Target: 450 | Upside : 19.3%
Target
Axis Direct
we maintain a BUY rating on the stock.
Biocon Ltd.'s price crossed below 30Day SMA today
More from Biocon Ltd.
Recommended
Market trades higher, Bandhan Bank's promoter reportedly plans a stake sale
Trendlyne Marketwatch |
16 Mar 2026, 03:25PM
Five Interesting Stocks Today - March 13, 2026
The Baseline |
13 Mar 2026
A long drawn out R&D plan may be finally paying off for Biocon
|
20 Aug 2020